NDLI: US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Please wait, while we are loading the content...

Geldanamycin, an inhibitor of Hsp90, Blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains

Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection

Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems

Concluding summary: Proceedings of the AAPS Biotec Open Forum on “Aggregation of Protein Therapeutics”

In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system

Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometry

NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity

Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation

Endocannabinoid metabolomics: A novel liquid chromatography-mass spectrometry reagent for fatty acid analysis

2005 AAPS Biotechnology Conference Open Forum on Aggregation of Protein Therapeutics — Panel Discussion June 5–8, 2005 San Francisco, CA

Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Vesicular monoamine transporter 2: Role as a novel target for drug development

Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function

Endocannabinoid mechanisms of pain modulation

The AAPS Journal : Volume 8, Issue 3, September 2006

The AAPS Journal : Volume 8, Issue 2, June 2006

The AAPS Journal : Volume 8, Issue 1, March 2006

The AAPS Journal : Volume 7

The AAPS Journal : Volume 6

The AAPS Journal : Volume 5

The AAPS Journal : Volume 4

The AAPS Journal : Volume 3

The AAPS Journal : Volume 2

The AAPS Journal : Volume 1

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Content Provider	Springer Nature Link
Author	Williams, Roger L.
Copyright Year	2006
Abstract	The United States Pharmacopeial Convention (the USP Convention), which meets at 5-year intervals, last convened in 2005. At that meeting, the convention membership elected a new Council of Experts for the 2005–2010 cycle. In turn, the Council elected members of Expert Committees charged with updating and revising the United States Pharmacopeia-National Formulary (USP-NF) and developing other authoritative standards and information. As one of their final activities, Expert Committees from the 2000–2005 cycle and USP staff carefully reviewed their work from the 2000–2005 cycle and reexamined the contents of USP-NF. From this comprehensive inventory emerged an updated and more focused new work plan directed toward acquiring missing monographs, updating monographs (typically because of advances in analytical technologies), and attending to General Chapter work (eg, dividing the General Chapter Chromatography <621> into smaller chapters) during the 2005–2010 cycle. Several elements of the work plan also speak to Resolutions adopted at the March 2005 Convention (available at www.usp.org/aboutUSP/resolutions. html) and prior ones as well. Because the work plan involves new approaches that affect both General Chapters (and thus the performance of tests and procedures) and monograph specifications—as well as the function of Pharmacopeial Forum and the introduction of new products—USP expects the plan to have a broad impact. This article briefly reviews some of these anticipated changes, informs constituents about how they can remain updated about progress and upcoming modifications to official texts, and invites participation in the standards-setting process.
Starting Page	E661
Ending Page	E664
File Format	PDF
ISSN	12341234
Journal	The AAPS Journal
Volume Number	8
Issue Number	4
e-ISSN	15507416
Language	English
Publisher	Springer-Verlag
Publisher Date	2006-01-01
Publisher Institution	American Association of Pharmaceutical Scientists
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	US Pharmacopeia United States Pharmacopeia-National Formulary USP-NF Pharmacopeial Forum monograph Pharmacy Pharmacology/Toxicology Biotechnology
Content Type	Text
Resource Type	Article

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus

Shear-induced variability in the United States pharmacopeia apparatus 2: Modifications to the existing system

Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs

Dissection of USP catalytic domains reveals five common insertion points

The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets—Quality Attributes and Experimental Variables Contributing to Dissolution Variance

In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES$^{™}$) in multi-pH media using United States Pharmacopeia apparatus II and III

Does the United States Pharmacopeia Throat Introduce De-agglomeration of Carrier-Free Powder from Inhalers?

The USP Performance Verification Test, Part II: Collaborative Study of USP’s Lot P Prednisone Tablets

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Similar Documents

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements

Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus

Shear-induced variability in the United States pharmacopeia apparatus 2: Modifications to the existing system

Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs

Dissection of USP catalytic domains reveals five common insertion points

The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets—Quality Attributes and Experimental Variables Contributing to Dissolution Variance

In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES$^{™}$) in multi-pH media using United States Pharmacopeia apparatus II and III

Does the United States Pharmacopeia Throat Introduce De-agglomeration of Carrier-Free Powder from Inhalers?

The USP Performance Verification Test, Part II: Collaborative Study of USP’s Lot P Prednisone Tablets

US pharmacopeia council of experts 2005–2010: Work plans, new revision approaches, and other enhancements